A positive efficacy readout should certainly boost the share price. Not only because of its significance for PYC's lead asset, but also because it would provide proof of concept for PYC's platform technology.
- Forums
- ASX - By Stock
- New valuation of PYC
PYC
pyc therapeutics limited
Add to My Watchlist
1.89%
!
$1.30

A positive efficacy readout should certainly boost the share...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M |
Open | High | Low | Value | Volume |
$1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | $1.29 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.32 | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 700 | 1.250 |
2 | 22000 | 1.220 |
2 | 2166 | 1.200 |
1 | 8474 | 1.180 |
1 | 6000 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.320 | 10000 | 1 |
1.330 | 3633 | 1 |
1.340 | 9300 | 1 |
1.420 | 26097 | 2 |
1.425 | 25000 | 1 |
Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online